|
Clinical Trial for Low Grade (Grade II) Glioma Patients Now Open and Accepting Patients |
 |
 |
 |
|
Written by Barb Gibbs
|
|
Wednesday, 11 January 2012 15:57 |
|
(Clearwater, FL) January 11, 2012 -- Miles For Hope announced today that the brain tumor vaccine clinical trial, Optimizing Dendritic Cell Vaccination for Low Grade Glioma Patients, is now open and accepting new patients. Patients must have a Grade II Brain Tumor and surgery at UCLA to qualify for the trial. The trial is a Phase II Clinical Trial Evaluating Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Low-grade Gliomas.
This clinical trial was proudly funded by Miles For Hope, Accelerate Brain Cancer Cure and The Stephen M. Coffman Charitable Trust. In July 2011, these non-profit organizations came together to jointly fund a $100,000 research grant to University of California Los Angeles (UCLA) neurosurgeon Linda Liau, M.D., PhD to begin this clinical trial, Optimizing Dendritic Cell Vaccination for Low Grade Glioma Patients. This is the first trial of its kind for patients that have been diagnosed with low grade gliomas, a common form of brain cancer. This research has the potential to improve the lives of brain cancer patients.
|
|
|
Robert (Bob) Gibbs loses his 7-year battle with brain cancer |
|
|
|
|
Written by Barb Gibbs
|
|
Thursday, 05 January 2012 15:29 |
|
CLEARWATER, FL – Robert (Bob) Gibbs, Founder of Miles For Hope, Inc., a non-profit organization, passed away Saturday December 10th, 2011 at 2:05 a.m., after a seven-year battle with brain cancer. Gibbs, 42, died peacefully with family by his side.
Gibbs was a leader in the brain tumor community. His focus through Miles For Hope was to raise awareness and funding for cutting-edge brain tumor research and clinical trials.
|
|
Last Updated on Wednesday, 11 January 2012 16:04 |
|
Wednesday, 15 December 2010 11:33 |
|
Our Brain Tumor Walk is designed to raise critically needed awareness and funding for brain tumors. Our National Brain Tumor Walks bring individuals, teams and communities together for a day of inspiration, fun and awareness for brain tumors. Our Moving Towards A Cure® Brain Tumor Walks are organized by Miles for Hope staff and volunteers within the brain tumor community.
|
|
|
Miles For Hope Helps Fund $100,000 UCLA Brain Cancer Vaccine Trial |
|
|
|
|
Written by Bob Gibbs
|
|
Wednesday, 06 July 2011 08:27 |
|
Accelerated Brain Cancer Cure Foundation and Stephen M. Coffman Charitable Trust Join Miles For Hope in Funding $100,000 Grant For Brain Tumor Research
(Clearwater, FL) July 6, 2011 -- Miles For Hope announced today that it has partnered with two brain tumor organizations, Accelerated Brain Cancer Cure Foundation (ABC2) and the Stephen M. Coffman Charitable Trust, in awarding a $100,000 research grant to University of California Los Angeles (UCLA) neurosurgeon Linda Liau, M.D., PhD to begin the clinical trial, Optimizing Dendritic Cell Vaccination for Low Grade Glioma Patients. This is the first trial of its kind for patients that have been diagnosed with low grade gliomas, a common form of brain cancer. This grant is the collaboration to fund research that has the potential to improve the lives of brain cancer patients.
|
|
Last Updated on Wednesday, 11 January 2012 16:05 |
|
|
